Genus Oncology
Vernon Hills · Founded 2007
About Genus Oncology
Genus Oncology was formed in 2007 with a mission of discovering, developing, and commercializing new anti-cancer agents that target the Mucin 1 (MUC1) oncoprotein. The incidence of overexpressed MUC1 in a wide array of carcinomas and hematologic malignancies has been known by researchers for many years. Until now, no viable approach existed to selectively target and block the function of MUC1 that leads to the formation of tumors.
Company Facts
- Founded: 2007
- Legal name: Genus Oncology, LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Funding stage: Early Stage Venture
- Last round: Series A (May 2011)
- Website: genusoncology.com
- Phone: 8475496500
Social Profiles
Canonical: https://fsome.com/organization/genus-oncology-8396381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.